Pharm Frontier: An Interview with Eddie Sullivan
Clip: Season 21 | 19m 16s
From www.sabbiotherapeutics.com Utilizing the most advanced antibody science in the world, SAB is delivering the world’s first large scale platform to create fully human, polyclonal antibodies. Cara Hetland visits with Eddie Sullivan, president and co-founder, about advances that the company is making in medicine.
Aired: 01/29/19Video has closed captioning.